Difference between revisions of "Table 1 - Advantages and disadvantages of different therapeutic protein production platforms (From DOI: 10.3390/pathogens9020148) (Q7908)"
Jump to navigation
Jump to search
(Created a new Item: #quickstatements; #temporary_batch_1585881142088) |
(Created claim: occurs in (P94): Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development (DOI: 10.3390/pathogens9020148) (Q7889), #quickstatements; #temporary_batch_1585881227380) |
||
| Property / occurs in | |||
| + | |||
| Property / occurs in: Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development (DOI: 10.3390/pathogens9020148) / rank | |||
| + | Normal rank | ||
Latest revision as of 02:33, 3 April 2020
Table appearing in "Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development" in the MDPI journal Pathogens (2020); DOI: 10.3390/pathogens9020148
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Table 1 - Advantages and disadvantages of different therapeutic protein production platforms (From DOI: 10.3390/pathogens9020148)
|
Table appearing in "Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development" in the MDPI journal Pathogens (2020); DOI: 10.3390/pathogens9020148
|
